Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 10/20 | 0.55 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13805761 | 0.82 | LTA4H (0.43) | LTA4HSRD5A2L3MBTL1 | |
| SCHEMBL6795974 | 0.80 | LMNA (0.60) | SRD5A2L3MBTL1LMNACYP1A2CYP2C19 | |
| SCHEMBL20943 | 0.79 | LTA4H (0.45) | LTA4HL3MBTL1CYP2C9CYP2C19 | |
| Benzene SCHEMBL11134259 | 0.79 | LTA4H (0.45) | LTA4HL3MBTL1CYP2C9CYP2C19 | |
| SCHEMBL29790853 | 0.79 | LTA4H (0.45) | LTA4HL3MBTL1CYP2C9CYP2C19 | |
| SCHEMBL14264187 | 0.79 | LTA4H (0.50) | LTA4HCALM1PPARGPPARASRD5A2 | |
| SCHEMBL31506395 | 0.77 | LTA4H (0.43) | LTA4HL3MBTL1 | |
| SCHEMBL11350262 | 0.77 | LTA4H (0.43) | LTA4HL3MBTL1 | |
| SCHEMBL5883808 | 0.77 | LTA4H (0.43) | LTA4HL3MBTL1 | |
| Lithium SCHEMBL31429159 | 0.77 | LTA4H (0.43) | LTA4HL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8604233-B2 | Lubricant composition, magnetic recording medium, and novel polyether compound | FUJIFILM CORPORATION (JP) | 2013-12-10 | — | — | US | disclosed |
| US-7812171-B2 | Black pigment, black pigment dispersion and black resin composition comprising the same | FUJIFILM CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100247971-A1 | LUBRICANT COMPOSITION, MAGNETIC RECORDING MEDIUM, AND NOVEL POLYETHER COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20080262237-A1 | BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME | FUJIFILM CORPORATION (JP) | 2008-10-23 | — | — | US | disclosed |
| US-20060083954-A1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. | 2006-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247971-A1 | LUBRICANT COMPOSITION, MAGNETIC RECORDING MEDIUM, AND NOVEL POLYETHER COMPOUND | MUC1, NEFM, CA13 | LTA4H 2055/4885CALM1 3388/4885PPARG 2655/4885 |
| US-20080262237-A1 | BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME | DYNLL1, HNRNPL, AOX1 | LTA4H 880/4885CALM1 4129/4885PPARG 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.